A vaccine being developed in conjunction with U.S. firm Celldex Therapeutics, claims to kill off the most deadly cancers including breast, bowel and cervical tumours. The problem is, it will also destroy a women's ability to reproduce.

Professor Iles, of Middlesex University, stated that a form of Human chorionic gonadotropin (hCG) is made by around half of bladder and pancreatic-cancers. Some breast, bowel, ovarian and cervical tumours also pump it out.

According to Iles' research, the injection will rev up the immune system, directing it to destroy hCG. He claims this will shrink tumours and crucially, stops them from spreading, or metastasizing.
Fertility and Human Chorionic Gonadotropin (hCG)

Human Chorionic Gonadotropin is a hormone produced in pregnancy that is made by the developing embryo after conception and later by the placenta. Its role is to prevent the disintegration of the hormonal structure of the ovaries and thereby maintains progesterone production that is critical for pregnancy in women. hCG also affects the immune tolerance of the pregnancy.

Perhaps an ulterior motive was the driving force behind such irresponsible research since scientists have known for decades that any attempts to depress or destroy hCG may lead to permanent infertility in women.

Ironically, the hCG hormone the researchers are trying to destroy is actually used during female infertility treatments in order to stimulate the release of eggs from the ovaries. Temporary depression and disruption of hCG causes a range of hormonal imbalances and is considered a leading cause of miscarriages. Consequently, many once infertile women may suddenly conceive with repeated injections of hCG.

The biological processes of how hCG disrupts pregnancy also differ between different species so translating biological mechanisms from animal testing to humans is redundant. Regardless, drug studies continue to use these results if their conclusions and outcome are favourable to their objectives.

The duration of disruptions to the flow of hCG in women could be dramatic after women absorb this vaccine. It may completely deteriorate hCG receptors resulting in its inability to interact with the receptors of other critical hormones (i.e. luteinizing hormone) which are responsible for initiating and maintaining pregnancy. These issues are not even addressed in any of the studies conducted by Celldex Therapeutics or Professor Iles.

The researchers admit that the destruction of hCG will also mean the vaccine will act as a contraceptive. However, what Professor Iles does not reveal is that since they have no protocol to study the long-term pharmacokinetics (bodily absorption, distribution, metabolism and excretion of the vaccine), there is no way of knowing if a women's fertility will ever be restored or return to normal levels after completing treatment. In essence, regardless of age, these women could be left sterile for life.

Their partnership with Rockfellar University is directed towards providing an HIV vaccine with additional funding partnerships from the Bill & Melinda Gates Foundation who have recently come under fire for their advocacy of sterility agents in vaccines.

The introduction of such a vaccine will set a dangerous precedent in the medical community to administer a "last resort" vaccine for people diagnosed with "incurable metastasized cancers." In actuality, the term "incurable cancer" is a misnomer. There have always been very effective complementary and alternative solutions for every type of cancer regardless of stage or defined curability rates. The problem is that regulatory health agencies and conventional medicine refuse to acknowledge and frequently surpress the effectiveness of such remedies. Moreover, subjecting women to lethal vaccine chemicals in a "last resort" vaccine will only further subject them to deteriorating health and prevent them from getting the natural anti-cancer remedies they need to restore their health.

Dave Mihalovic is a Naturopathic Doctor who specializes in vaccine research, cancer prevention and a natural approach to treatment.